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Abstract
“A:a” knob–hole interactions and D:D interfacial interactions are important for fibrin polymerization.
Previous studies with recombinant γN308K fibrinogen, a substitution at the D:D interface, showed
impaired polymerization. We examined the molecular basis for this loss of function by solving the
crystal structure of γN308K fragment D. In contrast to previous fragment D crystals, the γN308K
crystals belonged to a tetragonal space group with an unusually long unit cell (a = b =95Å, c = 448.3
Å). Alignment of the normal and γN308K structures showed the global structure of the variant was
not changed and the knob “A” peptide GPRP was bound as usual to hole “a”. The substitution
introduced an elongated positively charged patch in the D:D region. The structure showed novel,
symmetric D:D crystal contacts between γN308K molecules, indicating the normal asymmetric D:D
interface in fibrin would be unstable in this variant. We examined GPRP binding to γN308K in
solution by plasmin protection assay. The results showed weaker peptide binding, suggesting that
“A:a” interactions were altered. We examined fibrin network structures by scanning electron
microscopy and found the variant fibers were thicker and more heterogeneous than normal fibers.
Considered together, our structural and biochemical studies indicate both “A:a” and D:D interactions
are weaker. We conclude that stable protofibrils cannot assemble from γN308K monomers, leading
to impaired polymerization.
Fibrinogen is a 340 kDa plasma glycoprotein composed of six polypeptide chains, (Aα, Bβ,
γ)2, folded into three distinct structural regions: two distal D regions linked by coiled-coil
connectors to one central E region forming a trinodular molecule (see Figure 1) (1). The
symmetric D regions contain the polymerization holes “a” and “b” located in the C-terminus
of the γ- and Bβ-chains, respectively. The central E region contains two sets of polymerization
knobs “A” and “B” that are cryptic in fibrinogen but become exposed in fibrin after thrombin
cleaves fibrinopeptides A (FpA) and B (FpB) from the N-terminus of the Aα- and Bβ-chains,
respectively. In the proposed model of polymerization (Figure 1) (1), the exposed knobs “A”,
which start with the sequence Gly-Pro-Arg-, bind to holes “a” in two other fibrin molecules
forming “A:a” interactions. Because the fibrin monomers are symmetric, these and the
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reciprocal “A:a” interactions lead to a double-stranded protofibril with a half-staggered overlap
between molecules in different strands. The end-to-end alignment of monomers in each
protofibril strand abuts the γ-chains of two adjacent molecules to form the D:D interface.
Subsequently, FpB is released, and the protofibrils assemble in three dimensions to form a
branched network of fibers. The fibrin network is stabilized by the transglutaminase FXIIIa,
which catalyzes formation of intermolecular cross-links between fibrin monomers. Because
cross-links form between γ-chains, it is possible to isolate a fibrin fragment, called double-D,
containing the D:D interface.
Even though the adjoined D regions are identical, crystallography studies have shown the D:D
interface in double-D is asymmetric (Figure 1). The asymmetric interactions include only a
few potential hydrogen bonds and no obvious salt links (2). The functional significance of these
interactions is evident in several dysfibrinogenemia cases involving substitution at one residue
within the D:D interface, γ308Asn. Patients with a Lys substitution, γN308K, have been
associated with thrombosis or bleeding (3). Fibrinogen Kyoto I was isolated from a hypo-
fibrinogenemic patient who had a family history of both thrombosis and bleeding (4).
Fibrinogen Bicetre II was found in a patient who suffered pulmonary embolism (5). Fibrinogen
Matsumoto II was isolated from a patient with a history of severe bleeding (6). In contrast, the
Ile substitution, γN308I, was identified in an asymptomatic patient (fibrinogen Baltimore III)
(7).
Biochemical analysis of recombinant fibrinogens γN308K, γN308I, and γN308A showed all
three had impaired polymerization in the absence of added calcium (8). At 0.1 mM calcium,
polymerization of both γN308I and γN308A was nearly normal while polymerization of
γN308K remained markedly impaired even at 5 mM calcium. FXIIIa-catalyzed γ–γ dimer
formation was also significantly delayed in γN308K. These studies suggest that a critical aspect
of polymerization in conjunction with calcium binding is disrupted in γN308K (8).
Nevertheless, calcium binding studies with γN308K fragment D derived from the Kyoto
patient’s fibrinogen showed essentially identical binding when compared to normal fragment
D (9). Although γ308Asn is located at the D:D interface, crystal structures show this residue
is also near polymerization hole “a” and the calcium binding site, γ1. Whether or not the
γN308K substitution impacts the D:D interface, “A:a” interactions, or γ1 calcium binding
remains unclear.
In this study, we examined the structural basis for the functional impairment of γN308K. We
crystallized fragment D from γN308K in the presence of the peptide GPRP, which mimics
knob “A”, and solved the 3.05 Å structure (rfD-γN308K + GP, PDB code 3HUS). We
characterized calcium binding and “A:a” interactions in γN308K using a plasmin protection
assay. We performed scanning electron microscopy to examine the variant clot structure. Our
biochemical and structural data suggest γ308Asn is critical for stable protofibril formation, not
only for the D:D interface that forms during end-to-end association of fibrin molecules but also
for the structural integrity of loops that influence “A:a” knob–hole interactions.
EXPERIMENTAL PROCEDURES
Reagents
All chemicals were of reagent grade and were purchased from Sigma-Aldrich (St. Louis, MO),
unless specified otherwise. The peptide GPRP-amide was purchased from Bachem Americas,
Inc. (Torrance, CA). Cell culture media with normal recombinant fibrinogen were obtained
from the National Cell Culture Center (Minneapolis, MN). Monoclonal IF-1 antibody was
purchased from Kamiya Biomedical (Seattle, WA). All molecular graphics were illustrated
using PyMol (DeLano Scientific LLC, Palo Alto, CA).
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Expression and Purification of Recombinant γN308K
Normal and variant fibrinogen γN308K were synthesized in CHO cells as described (8). Large-
scale protein expression was carried out in serum-free medium in roller bottles. Media
containing secreted fibrinogen were harvested periodically. After addition of protease
inhibitors, the media were stored at −20 °C.
Recombinant fibrinogen was purified as described (10). Briefly, fibrinogen was precipitated
from the media with ammonium sulfate in the presence of protease inhibitors. The precipitate
was resuspended in buffer containing 10 mM CaCl2 and applied to a Sepharose 4B column
coupled with the calcium-dependent monoclonal antibody, IF-1. Fibrinogen was eluted with
5 mM EDTA, dialyzed once against 20 mM HEPES, pH 7.4, 150 mM NaCl (HBS), and 1 mM
CaCl2. The protein was extensively dialyzed against HBS and then stored at −80 °C. The
integrity of the polypeptides and the purity of the recombinant protein were analyzed by SDS–
PAGE under reduced and nonreduced conditions following the method of Laemmli (11).
Preparation and Purification of Fragment D
Fragment D was prepared from γN308K by controlled trypsin digestion as described (12,13).
Briefly, CaCl2 (final concentration of 20 mM) was added to 10 mg of γN308K at 0.7 mg/mL
in HBS, and digestion was initiated by adding a 100 μL slurry of bead-immobilized TPCK
trypsin (Pierce Biotechnology Inc., Rockford, IL). The reaction proceeded over a period of
days at room temperature until SDS–PAGE revealed essentially two bands that correspond to
the molecular weights of fragments D and E. Digestion was stopped by removing the trypsin
beads with centrifugation at 1200 × g (Sorvall RC-3) for 10 min. Fragment D was purified by
peptide affinity chromatography as described with modification (12,13). Briefly, the digest
was loaded onto a polymeric resin covalently linked to the peptide GPRPAA. Fragment D was
eluted using 50 mM sodium acetate, pH 5.3, and 1 M NaBr. Purified fragment D was dialyzed
against 50 mM Tris-HCl, pH 7.4, then concentrated to about 30 mg/mL with a centrifugal filter
device (50 kDa MW cutoff; Millipore Corp., Billerica, MA), and stored at 4 °C.
Crystallization of γN308K Fragment D
Purified γN308K fragment D was cocrystallized with GPRP by sitting-drop diffusion at 4 °C
as previously described (2,12,13). Crystals were grown from drops containing 5 μL of γN308K
fragment D at 10 mg/mL in 50 mM Tris-HCl, pH 7.4, and GPRP at 5 mM. The protein–peptide
solution was mixed with 5 μL of crystallization solution containing 50 mM Tris-HCl, pH 8.5,
2 mM NaN3, 12.5 mM CaCl2, and 9% (w/v) PEG 3350. Single crystals appeared in days,
following streak seeding with crystals of normal recombinant fragment D.
X-ray Diffraction Data Collection and Structure Determination
Data collection for crystals of γN308K fragment D cocrystallized with GPRP (rfD-γN308K +
GP) was carried out at 100 K using beamline X29A at the National Synchrotron Light Source
at Brookhaven National Laboratory. A single crystal was cryoprotected in a loop containing
the crystallant solution plus 20% glycerol and 5 mM GPRP and then flash-frozen in liquid
nitrogen. Initial screening revealed the crystal had a long c cell edge; hence, oscillation data
were recorded at a crystal-to-detector distance of 350 mm to achieve adequate diffraction spot
separation. The data were processed with DENZO and scaled in ScalePack (14).
The native Patterson map showed a large peak at fractional coordinates of (0, 0, 0.472)
suggesting the presence of a translational noncrystallographic symmetry (NCS). To generate
a model for molecular replacement, the coordinates of one molecule of the normal recombinant
fragment D (PDB code 1LT9) were used as a starting point. Using the Superpose program in
CCP4 (15), another copy of the molecule was generated by translation using the orthogonal
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coordinates (0, 0, 0.472c), where c is the length of the c cell edge (448.3 Å). The coordinates
of the original and the translated molecules were put together to make up a new model
consisting of two molecules separated by the NCS translation. Using the automated search
mode in PHASER (16) and the two-molecule search model, the structure of rfD-γN308K + GP
was solved. The resulting model was refined using Refmac 5 (17), reserving 5% of the
reflections for the calculation of the Rfree factor. After one round of refinement, the model was
improved by manual fitting with the program Coot (18) using sigmaA-weighted ∣2Fo – Fc∣and
∣Fo – Fc∣ electron density maps (19). Water molecules and cis-peptide bonds were added at
positions Bβ407 and γ339 to complete the model. Final refinement was done with the TLS
protocol in Refmac 5 (20). After these refinement steps, the Rcryst and Rfree converged to the
values reported in Table 1.
Analysis of the Molecular Packing in γN308K
Because γ308Asn involves mutation at the D:D interface of adjacent fibrin units, we examined
the molecular packing of rfD-γN308K + GP using MSDPisa (21). We analyzed the D:D crystal
contacts of the recombinant fragment D structures and compared these to the actual D:D
interface observed in the FXIIIa cross-linked double-D structure.
Scanning Electron Microscopy (SEM)
Specimen preparations were based on a previously described method with some modifications
(22). For each polymerization condition, SEM was performed on two clots each with two
separate microscopy preparations for normal and γN308K fibrinogen. Clots (100 μL) were
polymerized for 4 h in 96-well microtiter plates using 0.5 mg/mL fibrinogen and 0.4 unit/mL
thrombin in HBS without added CaCl2 or with 5 mM CaCl2. The clots were fixed in 2%
glutaraldehyde overnight, rinsed three times with HBS, and dehydrated with a series of ethanol
solutions (20–100%). The samples were dried in a Samdri-795 critical point dryer (Rockville,
MD), mounted, sputter-coated with approximately 20 nm of gold–palladium, and viewed on
a Zeiss Supra 25 FESEM (Carl Zeiss MicroImaging, Inc., Thornwood, NY). Images were taken
at high (101000×) and low (21000×) magnifications, with a 9.0 mm working distance and 5
kV accelerating voltage. Fiber diameters were measured from the high magnification images
using the measurement tool in Photoshop (Adobe Systems, San Jose, CA).
Plasmin Protection Assay
This assay was adapted from previous studies (23). To examine calcium binding, CaCl2 or
EDTA (at 5 mM final concentration) was added to 5 μg of fibrinogen at 0.2 mg/mL in HBS.
To examine GPRP binding, varying concentrations of the peptide (2 μM, 20 μM, 0.1 mM, 0.5
mM, 1 mM, 5 mM, and 20 mM) were added to 5 μg of fibrinogen at 0.36 mg/mL in HBS
supplemented with 5 mM EDTA. Reactions were initiated by adding 2 μL of plasmin
(Haematologic Technologies, Inc., Essex Junction, VT) to a final concentration of 4.8 μg/mL.
The reaction was incubated for 4 h at 37 °C and then stopped by adding SDS–PAGE loading
buffer and heating at 100 °C for 5 min. The plasmin digests were analyzed by nonreducing
SDS–PAGE (7.5% gels).
RESULTS
Structure of rfD-γN308K + GP
We obtained the crystal structure of γN308K fragment D with bound GPRP at 3.05 Å (see
Table 1). While many crystal structures of fragment D had an orthorhombic space group
(P212121) (12,13,24–28), rfD-γN308K + GP had a tetragonal unit cell (P43212) with
dimensions a = b = 95 Å and c = 448 Å. The native Patterson map indicated a translational
noncrystallographic symmetry, which prompted us to adopt a different strategy for molecular
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replacement as described in Experimental Procedures. The resulting structure solution gave a
rotation and translation Z scores of 47.5 and 53.8, respectively. The Rcryst and Rfree values prior
to any refinement were 42.6 and 41.5, respectively.
The change from asparagine to lysine at position γ308 was evident from the negative ∣Fo –
Fc∣ density around the carboxamide group when asparagine was modeled. Alignment of normal
rfD (PDB code 1LT9) and rfD-γN308K + GP showed excellent agreement with rmsd = 0.73
Å over Cα atomic positions. Thus, the global structure of γN308K fragment D was not changed
by the substitution. The substitution altered the charge distribution over the surface that makes
up the D:D interface, introducing an elongated positively charged patch in γN308K compared
to normal.
The rfD-γN308K + GP structure showed GPRP was bound to hole “a” (Figure 2A). This was
evident by the presence of positive electron density in ∣Fo – Fc∣ maps corresponding to the
peptide bound in the hole when GPRP was not modeled. Comparison of the rfD-γN308K + GP
structure with several fragment D structures showed only a subtle difference in the
conformation of GPRP in hole “a”, well within the reported variations in “knob–hole”
structures. GPRP was also bound to hole “b” (Figure 2B). These “A:b” interactions have been
seen in previous structures of D fragments cocrystallized with just the knob “A” peptide (25,
29). The data in Figure 2 also show calcium was present in the high-affinity calcium binding
site in the γ-chain (γ1) of rfD-γN308K + GP. The ion was ~22 Å away from γ308Lys. Calcium
was also present at the homologous position in the β-chain, designated as β1 site.
Crystal Packing in rfD-γN308K + GP
We compared the molecular packing in rfD-γN308K + GP crystals to those for normal fragment
D and several variant fragment D crystals. In contrast to all previous crystals, the D:D crystal
contacts between γN308K molecules were symmetric (Figure 3). For example, γ241Ala on one
molecule is adjacent to γ279Ala on the second, while γ241Ala on the second lies adjacent to
γ279Ala in the first. This finding is unique even among crystals of variant fibrinogens. Crystals
of fragment D from a variant with an altered hole “a” (PDB code 3BVH), or an altered hole
“b” (PDB code 3E1I), and variants with altered calcium binding sites (PDB codes 1RE3, 1RE4,
1RF0, and 1RF1; data not shown) all showed asymmetric D:D crystal contacts similar to those
in the normal fragment D crystals with (PDB code 1LTJ) or without (PDB code 1LT9) peptide
ligands (Figure 3). This finding suggests that the structure of the γN308K molecule is not
conducive to the formation of the normal, asymmetric D:D interface. As previously noted by
Everse et al. (30), the D:D contacts between individual fragment D molecules in crystals are
remarkably similar to the actual D:D interface of the FXIIIa cross-linked double-D fragment.
Because the structure of cross-linked double-D is thought to represent the D:D interfacial
interactions in protofibrils, they concluded that the crystallographic D:D contacts represent
those in fibrin protofibrils. Following this reasoning, our observation that the crystal contacts
in rfD-γN308K + GP, being different from all others, suggests this variant cannot form the D:D
interface of normal protofibrils. The symmetric D:D crystal contacts between γN308K
fragment D molecules involves new set of residues (Figure 3). While the normal asymmetric
interface involves residues within γ266-308, many of the contacts in rfD-γN308K + GP occur
at the C-terminal end of the γ-chain (γ389–394).
Plasmin Protection Assay
Because γ308Asn is close to the γ1 calcium site and hole “a”, we examined binding of calcium
or GPRP to γN308K using a plasmin protection assay. As previously shown, plasmin
proteolysis of normal fibrinogen was limited in the presence of calcium or GPRP (Figure 4A)
(31, 32). In the presence of calcium, the main cleavage product was fragment D1. In the
presence of EDTA, fragment D1 was further cleaved into the smaller fragments D2 and D3.
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Similar to normal fibrinogen, fragment D1 was the predominant product for γN308K in the
presence of 5 mM CaCl2, and the addition of 5 mM EDTA led to further digestion into D2 and
D3 (Figure 4B). These data are consistent with earlier experiments (9)that showed calcium
binding to fragment D from γN308K dysfibrinogen Kyoto I (Kd=3.2 μM) was the same as to
fragment D from normal fibrinogen (Kd=2.8 μM). Of note, the γN308K cleavage products that
we labeled D2 and D3 likely include cleavage at γ308K, as previously reported (9).
To assess binding of GPRP, we monitored proteolysis as a function of peptide concentration.
With normal fibrinogen, fragment D1 was readily evident at 20 μM GPRP, suggesting partial
protection at this peptide concentration (Figure 4A). The ratio of D1 to D2 and D3 increased
with increasing peptide concentration, and full protection was achieved for normal fibrinogen
at 5 mM GPRP. In contrast, for γN308K, fragment D1 was readily evident at 0.5 mM GPRP
(Figure 4B). Although the ratio of D1 to D2 and D3 increased with higher peptide
concentrations, full protection was not seen even at 20 mM GPRP. These findings suggest that
“A:a” interactions in γN308K are about 10-fold weaker than normal.
Scanning Electron Microscopy of Clots
Previous studies examined the polymerization of γN308K as changes in turbidity and found
that adding calcium did not markedly alter polymerization of this variant (8). To determine
whether the final turbidity accurately reflects the variant clot structure, we performed scanning
electron microscopy on clots at two calcium concentrations. As shown in Figure 5A, in the
absence of calcium, γN308K clots had thicker fibers (160 ± 45 nm) compared to normal (79 ±
18 nm, p < 0.05). Moreover, when we compared fiber size distribution by grouping fiber
diameters into 10 nm bins, we found a broader, apparently bimodal, distribution of fiber
diameters for the γN308K variant. As shown in Figure 5B, with 5 mM calcium the average
fiber diameter for normal clots increased to 99 ± 21 nm (p < 0.05), as anticipated. In contrast,
calcium did not significantly alter the fiber diameter for γN308K (158 ± 40 nm, p = 0.8). Fibers
in the variant clots were still significantly larger than normal, and the distribution of diameters
remained broader than the distribution for normal clots. Of note, in many images the thinner
fibers in γN308K clots twist together like cables to form thicker fiber bundles.
DISCUSSION
Taken together, our biochemical and structural studies suggest that stable protofibrils cannot
assemble from γN308K monomers, leading to impaired polymerization. Plasmin protection
assays showed “A:a” interactions are weaker than normal. The increased surface positive
charge and the unique molecular packing in the γN308K fragment D crystals suggest that
normal D:D interactions are destabilized by this substitution. As “A:a” and D:D interactions
are thought to support protofibril formation, we conclude that monomer assembly into
protofibrils is impaired in this variant. This conclusion is consistent with the findings of
Okumura et al. (8). FXIIIa-catalyzed cross-linking, which normally occurs coincident with
protofibril formation, is delayed for γN308K. FpB release, which occurs subsequent to
protofibril formation, is also delayed. The influence of calcium on polymerization is
diminished, consistent with previous findings that suggest the release of FpB is tied to the
calcium dependence of polymerization (22). It is notable, however, that polymerization of
γN308K fibrinogen is modestly impaired relative to other singly substituted γ-chain variants
that directly target either hole “a” (33) or the γ1 calcium binding site (23).
It is remarkable that the D:D crystal contacts in γN308K are symmetric. In all previously
reported normal and variant fragment D structures, the D:D crystal contacts between individual
molecules are similar to one another (Figure 3). Moreover, these contacts are similar to the
asymmetric interface between the D fragments in the cross-linked double-D structure, which
is considered a prototype of the D:D interface in the fibrin protofibril. (30). This consistency
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suggests the D:D crystal contacts in the previously reported D fragment structures represent
physiologically relevant interactions. Although crystal packing contacts differ in general from
natural contacts (34), protein crystals are stable physical phases so molecular packing in the
crystal may represent physiologically relevant protein–protein interactions (35). Indeed,
previous analysis has shown that crystals with 2-fold symmetry, as in these structures, are more
likely to have interfaces that resemble those in natural oligomers (36).
Recently, methods have been developed that may be able to determine a priori whether specific
crystal contacts represent physiological relevant interactions (37). In future work it could be
of interest to analyze the previous D:D crystal contacts with these methods. Because the
γN308K contacts differ from the contacts in all prior structures, we would anticipate that these
do not represent monomer interfaces in fibrin.
Previously, Yang et al. (38) proposed a model for fibrin polymerization based on the D:D
structure and the crystal contacts in fibrinogen structures. In order to provide some insight into
the impact of the substitution, we have incorporated the γN308K structure into the protofibril
from this model (Figure 6). With the normal, asymmetric D:D interface, the model
approximates two adjacent holes “a” such that the distance between the bound portion of knobs
“A” (α17–20) and the central E region is within the extended length of the missing six residues
and within the constraints imposed by the α28Cys–α28Cys disulfide bond (Figure 6A). The
link (α21–27) between knobs “A” (α17–20) and the central E region is indicated by the dashed
lines. We incorporated the D:D crystal contact observed in γN308K into the end-to-end
association of adjacent fibrin monomers, maintaining the estimated distance of ~80 Å between
two strands of the protofibril as shown in Figure 6B. The different D:D contacts would put the
two holes “a” on opposite sides of the junction, approximately 50 Å from the central E region.
The α17–27 link cannot span this distance, given the constraints of the α28Cys disulfide bond
(Figure 6B). Thus, the new D:D crystal contacts found in γN308K are not compatible with
“A:a” interactions. Assuming as we do with normal polymerization that “A:a” interactions lead
to formation of the D:D interface in fibrin, we conclude that the fragment D contacts seen in
the crystal packing of γN308K do not occur in the variant fibers. Rather, the D:D interface in
γN308K protofibrils is asymmetric, similar to that in the cross-linked double-D structure.
Because γN308K has an increased positive surface charge, the end-to-end alignment of
monomers will be destabilized by overall charge repulsion. Moreover, specific charge
repulsion is apparent when two γN308K fragment D molecules are modeled onto the cross-
linked double-D structure (2). In this structure γ308Asn is within hydrogen-bonding distance
with γ321Lys in the adjacent molecule (Figure 7A). When γN308K fragment D is superimposed
on each of the two D fragments in the double-D structure (Figure 7B), γ308Lys in one molecule
is only ~2 Å from γ321Lys in the adjacent molecule. Hence, steric clashing and charge repulsion
between these two basic residues are apparent if the variant assumes the normal D:D interface.
On the basis of our structure data, we conclude that γN308K monomers cannot form stable
protofibrils.
The plasmin protection assay showed weaker GPRP binding in γN308K indicating “A:a”
interactions were slightly altered in the variant. Because γ308Asn does not directly interact
with knob “A”, it is remarkable that the γN308K substitution also impaired hole “a”. We were
unable to crystallize fragment D from γN308K in the absence of GPRP, so this structure is not
available. However, comparison of the bound and unbound structures of normal fragment D
(Figure 8A,B) showed very similar conformations in the γ-chain loops (L1 and L2) that are
juxtaposed to loop 3 (L3). Loop 3 contains the γ338Lys-γ339Cys-γ340His backbone ridge that
supports knob “A” binding. We note that the γ308Asn side chain interacts with the backbone
atoms of γ278Tyr, which may limit the flexibility of L2 and stabilize hole “a”. Substitution
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with lysine would alter this interaction (Figure 8C), increasing the flexibility of L2, and thus
destabilize “A:a” interactions.
In summary, structural and biochemical analysis of γN308K fibrinogen leads us to conclude
that altered “A:a” interactions and charge repulsion in the D:D interface destabilize protofibril
formation in γN308K resulting to abnormal clot structure.
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Schematic representation of fibrin polymerization. Fibrinogen (A) is a dimer of three
polypeptide chains, Aα (in red), Bβ (in green), and γ (in blue). Removal of fibrinopeptides A
(FpA) in the central E region of the molecule exposes knobs “A” which bind to holes “a” in
the γ-chain, leading to the formation of protofibrils (B). Fibrin networks (C) form after lateral
aggregation of protofibrils. Factor XIIIa catalyzes the cross-linking of fibrin molecules.
Because cross-links form between neighboring γ-chains, it is possible to isolate a fragment,
called double-D, that contains the D:D interface. Crystallography studies of the double-D show
the D:D interface is asymmetric (D).
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Peptide binding in rfD-γN308K + GP. Knob “A” peptide mimic, GPRP (magenta sticks), was
bound to hole “a” in the γ-chain (A) and to hole “b” in the β-chain (B), as shown from the
∣Fo – Fc∣ maps calculated by omitting the coordinates of the peptide. Also shown are two
calcium ions (orange spheres) in the γ1 and β1 calcium binding sites.
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Comparison of end-to-end contacts observed in fragment D structures. In all prior fragment D
structures (C–F) the crystal contacts were asymmetric and resembled the D:D interface in the
naturally cross-linked double-D structure (A). In contrast, rfD-γN308K + GP, PDB code 3HUS
(B), showed symmetric end-to-end contacts involving a different set of residues. Calcium ions
in the γ1 binding site are shown as gray spheres while the peptide ligands bound to hole “a”
are shown in red. Structures shown above are as follows: (A) 1FCZ, cross-linked double-D
crystallized with GPRP and knob “B” peptide mimic, GHRP; (B) 3HUS, variant fragment D
from γN308K with GPRP; (C) 1LT9, normal recombinant fragment D crystallized without
peptides; (D) 1LTJ, normal recombinant fragment D crystallized with GPRP and GHRP; (E)
3BVH, variant fragment D from γD364A with GPRP; (F) 3E1I, variant fragment D from
BβD432A with GHRP.
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Plasmin protection assay analyzed by SDS–PAGE. Normal recombinant (A) or γN308K (B)
fibrinogen (~5 μg) containing 5 mM CaCl2, 5 mM EDTA, or increasing GPRP concentration
(supplemented with 5 mM EDTA) was incubated with 6 μg/mL plasmin for 4 h at 37 °C. The
digests were analyzed under nonreducing conditions on 7.5% gels. Plasmin cleavage products
are indicated on the right. The smaller fragments in γN308K may include cleavage at residue
308; thus these are labeled D2 and D3 (9). Of note, digests of recombinant fibrinogen produce
two fragments in the presence of calcium (13); we labeled these D1 and D1A.
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Scanning electron micrographs and fiber size distribution of γN308K clots. Fibrinogen (0.5
mg/mL) was incubated with 0.4 unit/mL thrombin without added calcium (panel I) and with
5 mM CaCl2 (panel II) for 4 h at 37 °C. Images of normal (B, D, G, I) and γN308K (C, E, H,
J) were recorded at 101000× (B, C, G, and H) and 21000× (D, E, I, and J) magnifications. The
black bar scale represents 100 nm for high magnification and 1 μm for lower magnification
images. Black arrows indicate thinner fibers in γN308K that twist together like cables to form
thicker fiber bundles. Fiber size distribution was determined by grouping fiber diameters into
10 nm wide bins starting with 20 nm and ending with 300 nm. The Gaussian fit curves in (A)
and (F) were generated using Origin (Northampton, MA).
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Models of protofibril interactions in normal and γN308K. These illustrations build on the model
of a protofibril proposed by Yang et al. (38). The D:D association in the normal double-D
structure (A) allows close proximity between two adjacent holes “a” such that the distance
between the bound knob A (α17–20) to the central E region is within the extended length of
six residues (dashed red line; missing in the structure) and within the constraints imposed by
the α28Cys–α28Cys disulfide bond. In γN308K (B), the different D:D interface puts the two
holes “a” in opposite sides of the junction approximately 50 Å away from the central E region,
a distance that α17–26 cannot span given the constraints of the α28Cys disulfide bond.
Bowley et al. Page 16














Modeling rfD-γN308K + GP into the normal double-D structure. Because the structure of
γN308K double-D is not available, individual γN308K fragment D was modeled into the
normal double-D structure (A). The γN308K double-D model (B) showed very close proximity
between γ308Lys and γ321Lys with a distance of ~2 Å.
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Comparison of bound and unbound forms of normal and γN308K. The conformations of γ-
chain loops L1, L2, L3, and L4 are similar in the normal unbound (A), normal bound (B), and
γN308K bound (C) structures, suggesting that knob “A” binding to hole “a” requires minimal
motion in surrounding loops. It appears that the side-chain interactions of γ308Asn with the
backbone atoms of γ278Tyr limit the flexibility of L2. Substitution with a bulkier lysine likely
alters γ308Asn–γ278Tyr interaction which then affects the motion of adjacent loops and
ultimately influences knob “A” binding.
Bowley et al. Page 18

























Bowley et al. Page 19
Table 1
Crystallographic Data and Refinement Statisticsa
data statistics
 resolution (Å) 50.0–3.05 (3.12–3.05)
 space group P43212
 cell constants a, b, c (Å) 95.0, 95.0, 448.3
 molecules/asymmetric unit 2
 total observations 324588
 unique reflections 40798
 mean redundancy 8.0
 Rsymb (%) 14.0 (54.3)
 completeness (%) 99.8 (99.9)
 mean I/σ 22.8 (4.0)
refinement statistics
 Rcrystc (%) 23.5
 Rfreed (%) 29.5
 average B factor (Å2) 61.8
 no. of model atoms 10711
 no. of solvent sites 101
rms deviations from ideals
 bond length (Å) 0.007
 bond angles (deg) 1.04
Ramachandran statistics
 most favored region (%) 91.6
 additionally allowed region (%) 8.2
a
Values in parentheses are statistics for the highest resolution shell.
b
Rsym =∑∣I – ⟨I⟩, where I is the observed intensity and ⟨I⟩ is the average intensity of multiple symmetry-related observations of that reflection.
c
Rcryst = ∑(∣Fo∣ – ∣Fc∣)/∑∣Fo∣, where Fo and Fc are the observed and calculated structure factors, respectively.
d
Rfree is the R-factor based on the 5% of the data withheld from structural refinement.
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